1-methyl-7-nitro-4-(5-(piperidin-1-yl)pentyl)-3,4-dihydroquinoxalin-2(1H)-one

ID: ALA2079504

PubChem CID: 70694536

Max Phase: Preclinical

Molecular Formula: C19H28N4O3

Molecular Weight: 360.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1C(=O)CN(CCCCCN2CCCCC2)c2ccc([N+](=O)[O-])cc21

Standard InChI:  InChI=1S/C19H28N4O3/c1-20-18-14-16(23(25)26)8-9-17(18)22(15-19(20)24)13-7-3-6-12-21-10-4-2-5-11-21/h8-9,14H,2-7,10-13,15H2,1H3

Standard InChI Key:  QQFYJLGIQOPALN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    7.7777  -18.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7766  -19.4398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4914  -19.8527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4896  -18.1997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2050  -18.6088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2084  -19.4373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9236  -19.8463    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6400  -19.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6366  -18.6030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9168  -18.1894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0625  -18.2004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3481  -18.6131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0623  -17.3754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9258  -20.6713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6414  -21.0819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3548  -20.6675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0704  -21.0780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7837  -20.6636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4993  -21.0741    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4958  -21.8965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2072  -22.3070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9230  -21.8960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9228  -21.0701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2067  -20.6550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3498  -18.1883    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9123  -17.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 13  1  0
  1 11  1  0
  3  6  2  0
  7 14  1  0
  1  2  2  0
 14 15  1  0
  5  4  2  0
 15 16  1  0
  4  1  1  0
 16 17  1  0
  5 10  1  0
 17 18  1  0
  6  7  1  0
 18 19  1  0
 19 20  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  5  6  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  2  3  1  0
  9 25  2  0
 11 12  2  0
 10 26  1  0
M  CHG  2  11   1  13  -1
M  END

Associated Targets(non-human)

Plasmodium yoelii yoelii (73 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania braziliensis (1091 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.46Molecular Weight (Monoisotopic): 360.2161AlogP: 3.03#Rotatable Bonds: 7
Polar Surface Area: 69.93Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.94CX LogP: 2.72CX LogD: 0.22
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.42Np Likeness Score: -1.22

References

1. Jiang X, Wu K, Bai R, Zhang P, Zhang Y..  (2022)  Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.,  229  [PMID:34998058] [10.1016/j.ejmech.2021.114085]

Source